Skip to main content


Fig. 5 | BMC Cancer

Fig. 5

From: Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma

Fig. 5

Phosphorylation antibody microarray analysis of KYSE30 cells treated with XMD8-92 and confirmation of pMEF2A modulation. a KYSE30 cells were treated (or not) for 2 h with 10 μM XMD8-92 and cell lysates were then prepared and analysed using phospho-antibody microarray. Actual microarray visualizations are presented. b KYSE30 cells were treated for 2 h with a range of XMD8-92 concentrations and cell lysates prepared for Western blotting using antibodies to detect pMEF2A (T312), total MEF2A and GAPDH

Back to article page